Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model

被引：0
|
作者：
Bekri, Selma
Uduman, Mohamed
Gruenstein, Diana
Mei, Anna Huo-Chang
Tung, Kaity
Rodney-Sandy, Reunet
Bogen, Bjarne
Buell, Jennifer
Stein, Robert
Doherty, Kaitlin
Findeis, Mark
Morin, Benjamin
Joshi, Bishnu
Tanne, Antoine
Castle, John
Levey, Daniel
Cho, Hearn Jay
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1868
引用
收藏
页数：3
相关论文
共 50 条
  • [31] A versatile pre-clinical in vivo model to evaluate the efficacy of T cell receptor gene therapy
    Leisegang, M.
    Kammertoens, T.
    Blankenstein, T.
    Uckert, W.
    HUMAN GENE THERAPY, 2013, 24 (12) : A45 - A46
  • [32] Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model
    Gebert, Johannes
    Gelincik, Ozkan
    Oezcan-Wahlbrink, Mine
    Marshall, Jason D.
    Hernandez-Sanchez, Alejandro
    Urban, Katharina
    Long, Mark
    Cortes, Eduardo
    Tosti, Elena
    Katzenmaier, Eva-Maria
    Song, Yurong
    Elsaadi, Ali
    Deng, Nan
    Vilar, Eduardo
    Fuchs, Vera
    Nelius, Nina
    Yuan, Yan P.
    Ahadova, Aysel
    Sei, Shizuko
    Shoemaker, Robert H.
    Umar, Asad
    Wei, Lei
    Liu, Song
    Bork, Peer
    Edelmann, Winfried
    Doeberitz, Magnus von Knebel
    Lipkin, Steven M.
    Kloor, Matthias
    GASTROENTEROLOGY, 2021, 161 (04) : 1288 - +
  • [33] Pre-clinical safety evaluation for mRNA-vaccine development in mouse model
    Ahn, J. H.
    Kwak, J. A.
    Kim, J. I.
    You, J. R.
    Cho, E. Y.
    Kwon, E. A.
    Keum, G. C.
    Nam, J. H.
    Yun, J. W.
    Kang, B. C.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A197 - A197
  • [34] Triple synergy between vaccine and checkpoint inhibitors in a pre-clinical tumor model
    Becker, William J.
    Olkhanud, Purevdorj B.
    Berzofsky, Jay A.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [35] Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates
    Benard, Angele
    Sala, Claudia
    Pluschke, Gerd
    PLOS ONE, 2016, 11 (11):
  • [36] A Central Effect of Ponesimod on Neuroinflammation in a Pre-Clinical Model of Multiple Sclerosis
    Fourgeaud, L.
    Le, M.
    Needham, A.
    Ait-Tihyaty, M.
    Lair, L. L.
    Breu, V.
    Wiegand, F.
    Truyen, L.
    Bhattacharya, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 105 - 105
  • [37] CANCER VACCINE TARGETING MYB IN COLORECTAL CANCER: FROM PRE-CLINICAL MODEL TO CLINICAL TRIAL
    Toan Pham
    Sampurno, Shienny
    Pereira, Lloyd
    Roth, Sara
    Narasimhan, Vignesh
    Carpinteri, Sandra
    Heriot, Alexander
    Desai, Jayesh
    Ramsay, Robert G.
    GASTROENTEROLOGY, 2018, 154 (06) : S1269 - S1269
  • [38] Pre-Clinical Models for CAR T-Cell Therapy for Glioma
    Vandecandelaere, Gust
    Ramapriyan, Rishab
    Gaffey, Matthew
    Richardson, Leland Geoffrey
    Steuart, Samuel Jeffrey
    Tazhibi, Masih
    Kalaw, Adrian
    Grewal, Eric P.
    Sun, Jing
    Curry, William T.
    Choi, Bryan D.
    CELLS, 2024, 13 (17)
  • [39] The Synergistic Effect of Melphalan and XPO1 Inhibition in Pre-Clinical Models of Multiple Myeloma
    Cui, Yan
    Turner, Joel G.
    Dawson, Jana L.
    Gomez, Juan A.
    Shain, Kenneth H.
    Meads, Mark B.
    Baloglu, Erkan
    Dalton, William S.
    Nishihori, Taiga
    Sullivan, Daniel M.
    BLOOD, 2016, 128 (22)
  • [40] Targeted radiotherapy for patients with multiple myeloma: Results of pre-clinical evaluation of candidate antibodies.
    Orchard, KH
    Cooper, M
    Mehta, A
    Potter, M
    Wijdenes, J
    Borchardt, P
    Quadri, S
    Goldman, J
    Samson, D
    Apperley, J
    Buscombe, J
    Hilson, A
    Myers, M
    Amlot, P
    Begent, R
    Prentice, HG
    BLOOD, 1999, 94 (10) : 302B - 302B
12345